Reversal of direct anticoagulants in patients with life threatening bleeding
Guideline on reversal of direct oral anticoagulants in patients with life threatening bleeding
Anticoagulation is essential for the treatment and prevention of thromboembolic events. Current guidelines recommend direct oral anticoagulants (DOACs) over vitamin K antagonists in DOAC-eligible patients. The major complication of anticoagulation is serious or life-threatening haemorrhage, which may necessitate prompt haemostatic intervention. Reversal of DOACs may also be required for patients in need of urgent invasive procedures. This guideline from the European Society of Anaesthesiology and Intensive Care (ESAIC) aims to provide evidence-based recommendations and suggestions on how to manage patients on DOACs undergoing urgent or emergency procedures including the treatment of DOAC-induced bleeding.
Important Disclaimers
- Please note that you can request permission to translate the guideline by contacting guidelines@esaic.org
- ESAIC Guidelines and related materials are for use by individuals only – either for personal or educational purposes. Commercial use of EAIC Guideline is not allowed. Permission to re-use the guidelines must be requested to guidelines@esaic.org.